相关实验视频
Updated: Jun 13, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
PDIA3-STAT3蛋白复合体通过CTSS/MHC-II通路介导的肠炎来调节IBS的形成和发展
Chunyan Weng1, Jingli Xu1, Xiao Ying2
1Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310000, Zhejiang Province, China.
这项研究表明,树突细胞中的蛋白质复合物PDIA3-STAT3通过改变免疫反应,有助于刺激性肠综合征 (IBS). 抑制这种复合物可能为IBS提供新的治疗策略.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 刺激性肠综合征 (IBS) 是一种功能性胃肠疾病,导致腹部疼痛和改变肠道习惯.
- 树突细胞 (DCs) 在免疫调节中发挥作用,可能与IBS病变发生有关.
研究的目的:
- 研究蛋白二硫化异构酶A3 (PDIA3) 和信号转换器和转录激活器3 (STAT3) 相互作用在IBS患者树突细胞中的作用.
- 阐明下游分子机制,将PDIA3-STAT3相互作用与IBS中的免疫激活联系起来.
- 评估PDIA3抑制对IBS的治疗潜力.
主要方法:
- 在IBS患者的树突细胞中分析PDIA3和STAT3表达和相互作用.
- 对化STAT3 (p-STAT3) 核转位的评估.
- 测量甲素S (CTSS) 和主要基因相容性复合物II类 (MHC-II) 的水平.
- 对CD4+T细胞增殖和细胞因子分泌 (IL-4,IL-6,IL-9,TNF-α) 的评估.
- 在体内研究使用IBS的老鼠模型,包括PDIA3下调和punicalagin的管理.
主要成果:
- 在IBS患者的树突细胞膜中观察到PDIA3和STAT3相互作用的增加.
- 这种相互作用减少了p-STAT3的核转移,导致CTSS和MHC-II水平增加.
- 激活的DCs促进了CD4+T细胞的增殖和促炎性细胞因子的分泌.
- 降低PDIA3和punicalagin的治疗缓解了老鼠的IBS症状,包括内脏过敏和 stool.
结论:
- 树突细胞中的PDIA3-STAT3蛋白质复合体通过调节免疫和炎症反应,是IBS发展的关键因素.
- 针对PDIA3-STAT3相互作用,为IBS提供了一个新的治疗途径.
- 像punicalagin这样的PDIA3抑制剂在缓解IBS症状方面表现有前途.
相关概念视频
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

